4//SEC Filing
MYERS ROBERT L 4
Accession 0001179110-20-009650
CIK 0001446159other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 8:56 PM ET
Size
29.1 KB
Accession
0001179110-20-009650
Insider Transaction Report
Form 4
MYERS ROBERT L
Chief Financial Officer
Transactions
- Award
Stock Options (Right to buy)
2020-09-04+53→ 53 totalExercise: $1.54Exp: 2022-08-13→ CommonStock (53 underlying) - Award
Stock Options (Right to buy)
2020-09-04+42→ 42 totalExercise: $1.54Exp: 2023-08-29→ Common Stock (42 underlying) - Award
Stock Options (Right to buy)
2020-09-04+14→ 14 totalExercise: $1.54Exp: 2024-03-07→ Common Stock (14 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−14→ 0 totalExercise: $4312.50Exp: 2024-03-07→ Common Stock (14 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−357→ 0 totalExercise: $41.98Exp: 2026-09-16→ Common Stock (357 underlying) - Award
Stock Options (Right to buy)
2020-09-04+30,411→ 30,411 totalExercise: $1.54Exp: 2027-06-22→ Common Stock (30,411 underlying) - Award
Stock Options (right to buy)
2020-09-04+16,600→ 16,600 totalExercise: $1.54Exp: 2029-04-04→ Common Stock (16,600 underlying) - Disposition to Issuer
Stock Options
2020-09-04−53→ 0 totalExercise: $1500.00Exp: 2022-08-13→ Common Stock (53 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−42→ 0 totalExercise: $1481.25Exp: 2023-08-29→ Common Stock (42 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−30,411→ 0 totalExercise: $14.70Exp: 2027-06-22→ Common Stock (30,411 underlying) - Award
Stock Options (Right to buy)
2020-09-04+357→ 357 totalExercise: $1.54Exp: 2026-09-16→ Common Stock (357 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2020-09-04−16,600→ 0 totalExercise: $7.48Exp: 2029-04-04→ Common Stock (16,600 underlying)
Holdings
- 77
Common Stock
Footnotes (4)
- [F1]All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020.
- [F2]Currently exercisable.
- [F3]12,450 shares are currently vested; 2,075 shares vest on each of 10/4/2020 and 1/4/2021.
- [F4]Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on October 29, 2019.
Documents
Issuer
Predictive Oncology Inc.
CIK 0001446159
Entity typeother
Related Parties
1- filerCIK 0001553600
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 8:56 PM ET
- Size
- 29.1 KB